Last 202.30 INR
Change Today +2.55 / 1.28%
Volume 74.9K
JBCP On Other Exchanges
Symbol
Exchange
Natl India
As of 6:08 AM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

j.b. chemicals & pharma ltd (JBCP) Snapshot

Open
202.50
Previous Close
199.75
Day High
207.95
Day Low
200.10
52 Week High
09/9/14 - 257.90
52 Week Low
01/30/14 - 115.10
Market Cap
17.2B
Average Volume 10 Days
134.7K
EPS TTM
7.26
Shares Outstanding
84.8M
EX-Date
09/4/14
P/E TM
27.9x
Dividend
3.00
Dividend Yield
1.48%
Current Stock Chart for J.B. CHEMICALS & PHARMA LTD (JBCP)

Related News

No related news articles were found.

j.b. chemicals & pharma ltd (JBCP) Related Businessweek News

No Related Businessweek News Found

j.b. chemicals & pharma ltd (JBCP) Details

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and APIs in India. The company offers generic products and formulations in the form of tablets, capsules, creams and ointments, injectables, liquid herbal syrups, and lozenges. It also manufactures iodinated contrast media, which are radiopaque substances used to study internal structures of the body in X-ray procedures, such as computed tomography and cardiac catheterization. In addition, the company’s APIs include atenolol USP, cilnidipine, diclofenac acid, and diclofenac diethylamine BP/EP. Further, it provides contract manufacturing services to pharmaceutical companies. The company also exports its products primarily to Russia, Ukraine, CIS countries, and South Africa. J. B. Chemicals & Pharmaceuticals Limited was founded in 1976 and is headquartered in Mumbai, India.

Founded in 1976

j.b. chemicals & pharma ltd (JBCP) Top Compensated Officers

Chairman, Managing Director and Member of Sha...
Total Annual Compensation: 16.0M
President, Director of Operations and Whole-T...
Total Annual Compensation: 7.7M
Director of Technical & Production and Execut...
Total Annual Compensation: 4.4M
Director of Administration, Whole-Time Direct...
Total Annual Compensation: 16.0M
Director of Planning & Development and Whole-...
Total Annual Compensation: 7.7M
Compensation as of Fiscal Year 2014.

j.b. chemicals & pharma ltd (JBCP) Key Developments

J. B. Chemicals & Pharmaceuticals Ltd. Appoints Devang R. Shah as an Additional Director

J. B. Chemicals & Pharmaceuticals Ltd. announced that the board of directors of the company has appointed Devang R. Shah as an additional director of the company. He is an independent director on the board.

J. B. Chemicals & Pharmaceuticals Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

J. B. Chemicals & Pharmaceuticals Ltd. reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported total income from operations of INR 2,748.6 million against INR 2,474.397 million for the same period previous year. Profit from operations before other income and finance costs was INR 475.547 million against INR 415.304 million for the same period of previous year. Profit from ordinary activities before tax was INR 426.830 million against INR 402.654 million for the same period of previous year. Net profit was INR 318.872 million or INR 3.76 per basic and diluted share compared to INR 331.427 million or INR 3.91 per basic and diluted share for the same period of previous year. For the six months, the company reported total income from operations of INR 5,315.731 million against INR 4,766.063 million for the same period previous year. Profit from operations before other income and finance costs was INR 860.078 million against INR 744.186 million for the same period of previous year. Profit from ordinary activities before tax was INR 852.377 million against INR 677.585 million for the same period of previous year. Net profit was INR 636.783 million or INR 7.51 per basic and diluted share compared to 534.682 million or INR 6.31 per basic and diluted share for the same period of previous year.

JB Chemicals & Pharmaceuticals Announces Resignation of Bansidhar S. Mehta as Non-Executive Director

JB Chemicals & Pharmaceuticals announced that Bansidhar S. Mehta, a non-executive director of the Company, has resigned from the board of directors of the Company due to regulatory restrictions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JBCP:IN 202.30 INR +2.55

JBCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JBCP.
View Industry Companies
 

Industry Analysis

JBCP

Industry Average

Valuation JBCP Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact J.B. CHEMICALS & PHARMA LTD, please visit www.jbcpl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.